Srsf2P95H 突变从造血干细胞起始髓系偏斜并引发骨髓增生异常/骨髓增殖性综合征
研究构建了在内源性位点生理性杂合表达 Srsf2P95H 的条件性小鼠模型,无需骨髓移植即可在造血干细胞群中诱发髓系单核细胞偏斜及转录和 RNA 剪接改变;随年龄增长出现可移植的进行性疾病,表现为髓系偏斜、形态发育异常和单核细胞增多,并获得人类 SRSF2 突变中反复出现的额外突变。
要点
- Srsf2P95H 需在含造血干细胞群体中表达才能引发髓系单核细胞偏斜和扩增。
- 非移植 Srsf2P95H 小鼠随年龄出现进行性、可移植的 MDS/MPN 样疾病。
- 该模型骨髓中出现人类 SRSF2 突变疾病中反复发生的额外突变。
核心结论
- Srsf2P95H 在天然造血过程中于含造血干细胞群体表达即可起始髓系偏斜并随年龄发展为可移植的 MDS/MPN 样疾病。
- 该可操作敲入模型与人类疾病高度相关,将用于阐明 SRSF2 突变在 MDS/MPN 起始和维持中的作用。
研究设计与样本
- 研究构建了新的条件性小鼠 Srsf2P95H 突变模型,P95H 突变在 Cre 激活后从内源性位点生理性、杂合性表达。
- 研究使用多种 Cre 品系,在无骨髓移植的天然造血条件下观察表型。
主要发现
- 在天然造血中,Srsf2P95H 突变需发生在含造血干细胞群体内才能促进髓系单核细胞偏斜和扩增,并伴相应转录和 RNA 剪接改变。
- 非移植 Srsf2P95H 动物随年龄出现进行性、可移植的疾病,特征为髓系偏斜、形态发育异常和单核细胞增多。
- 骨髓中共存突变分析显示获得人类 SRSF2 突变者中反复出现的额外突变。
局限性
- 原文指出先前两个 Srsf2P95H 小鼠模型不能再现 SRSF2 突变疾病的许多临床特征,且依赖骨髓移植应激来诱发所报告的表型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mutations in SRSF2 occur in myelodysplastic syndromes (MDS) and MDS/myeloproliferative neoplasms (MPN). SRSF2 mutations cluster at proline 95, with the most frequent mutation being a histidine (P95H) substitution. They undergo positive selection, arise early in the course of disease, and have been identified in age-related clonal hemopoiesis. It is not clear how mutation of SRSF2 modifies hemopoiesis or contributes to the development of myeloid bias or MDS/MPN. Two prior mouse models of Srsf2P95H mutation have been reported; however, these models do not recapitulate many of the clinical features of SRSF2-mutant disease and relied on bone marrow (BM) transplantation stress to elicit the reported phenotypes. We describe a new conditional murine Srsf2P95H mutation model, where the P95H mutation is expressed physiologically and heterozygously from its endogenous locus after Cre activation. Using multiple Cre lines, we demonstrate that during native hemopoiesis (ie, no BM transplantation), the Srsf2P95H mutation needs to occur within the hemopoietic stem-cell-containing populations to promote myelomonocytic bias and expansion with corresponding transcriptional and RNA splicing changes. With age, nontransplanted Srsf2P95H animals developed a progressive, transplantable disease characterized by myeloid bias, morphological dysplasia, and monocytosis, hallmarks of MDS/MPN in humans. Analysis of cooccurring mutations within the BM demonstrated the acquisition of additional mutations that are recurrent in humans with SRSF2 mutations. The tractable Srsf2P95H/+ knock-in model we have generated is highly relevant to human disease and will serve to elucidate the effect of SRSF2 mutations on initiation and maintenance of MDS/MPN.
引用
- Smeets MF, Tan SY, Xu JJ, et al. Srsf2P95H initiates myeloid bias and myelodysplastic/myeloproliferative syndrome from hemopoietic stem cells. Blood. 2018. PMID: 29903888. doi:10.1182/blood-2018-04-845602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。